A detailed history of Verdence Capital Advisors LLC transactions in Stryker Corp stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 1,621 shares of SYK stock, worth $632,319. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,621
Previous 1,353 19.81%
Holding current value
$632,319
Previous $460,000 27.17%
% of portfolio
0.05%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$315.94 - $371.96 $84,671 - $99,685
268 Added 19.81%
1,621 $585,000
Q2 2024

Jul 25, 2024

BUY
$324.3 - $354.67 $74,913 - $81,928
231 Added 20.59%
1,353 $460,000
Q1 2024

Apr 25, 2024

BUY
$293.94 - $358.71 $30,863 - $37,664
105 Added 10.32%
1,122 $401,000
Q3 2023

Oct 25, 2023

BUY
$266.54 - $302.43 $22,922 - $26,008
86 Added 9.24%
1,017 $277,000
Q2 2023

Jul 28, 2023

BUY
$271.49 - $305.09 $252,757 - $284,038
931 New
931 $284,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $148B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.